{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T12:49:18Z","timestamp":1792414158742,"version":"4.4.0"},"reference-count":162,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,20]],"date-time":"2024-04-20T00:00:00Z","timestamp":1713571200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011725","name":"Servier","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cancertreatmentreviews.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment Reviews"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.ctrv.2024.102737","type":"journal-article","created":{"date-parts":[[2024,4,21]],"date-time":"2024-04-21T02:34:09Z","timestamp":1713666849000},"page":"102737","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["The tumor immune composition of mismatch repair deficient and Epstein-Barr virus-positive gastric cancer: A systematic review"],"prefix":"10.1016","volume":"127","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7850-7205","authenticated-orcid":false,"given":"J.","family":"Bos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.S.","family":"Groen-van Schooten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.P.","family":"Brugman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.S.","family":"Jamaludin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.W.M.","family":"van Laarhoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Derks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ctrv.2024.102737_b0005","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ctrv.2024.102737_b0010","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.critrevonc.2017.12.019","article-title":"ECCO essential requirements for quality cancer care: Oesophageal and gastric cancer","volume":"122","author":"Allum","year":"2018","journal-title":"Crit Rev Oncol Hematol"},{"issue":"5","key":"10.1016\/j.ctrv.2024.102737_b0015","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1001\/jamaoncol.2016.5580","article-title":"Effect of fluorouracil, leucovorin, and oxaliplatin with or without onartuzumab in HER2-negative, MET-positive gastroesophageal adenocarcinoma: The METGastric randomized clinical trial","volume":"3","author":"Shah","year":"2017","journal-title":"JAMA Oncol"},{"issue":"3","key":"10.1016\/j.ctrv.2024.102737_b0020","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S1470-2045(18)30791-5","article-title":"Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, placebo-controlled, phase 3 trial","volume":"20","author":"Fuchs","year":"2019","journal-title":"Lancet Oncol"},{"issue":"31","key":"10.1016\/j.ctrv.2024.102737_b0025","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.1200\/JCO.2006.06.8429","article-title":"Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: A report of the V25 study group","volume":"24","author":"Van Cutsem","year":"2006","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ctrv.2024.102737_b0030","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/annonc\/mdu496","article-title":"Docetaxel plus oxaliplatin with or without fluorouracil or capecitabine in metastatic or locally recurrent gastric cancer: A randomized phase II study","volume":"26","author":"Van Cutsem","year":"2015","journal-title":"Ann Oncol"},{"issue":"7517","key":"10.1016\/j.ctrv.2024.102737_b0035","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nature13480","article-title":"Comprehensive molecular characterization of gastric adenocarcinoma","volume":"513","author":"Bass","year":"2014","journal-title":"Nature"},{"issue":"7903","key":"10.1016\/j.ctrv.2024.102737_b0040","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/s41586-022-04508-4","article-title":"Nivolumab plus chemotherapy or ipilimumab in gastro-oesophageal cancer","volume":"603","author":"Shitara","year":"2022","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.ctrv.2024.102737_b0045","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.annonc.2020.04.011","article-title":"Characterizing diversity in the tumor-immune microenvironment of distinct subclasses of gastroesophageal adenocarcinomas","volume":"31","author":"Derks","year":"2020","journal-title":"Ann Oncol"},{"issue":"9","key":"10.1016\/j.ctrv.2024.102737_b0050","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1158\/2159-8290.CD-21-0219","article-title":"Determinants of response and intrinsic resistance to pd-1 blockade in microsatellite instability\u2013high gastric cancer","volume":"11","author":"Kwon","year":"2021","journal-title":"Cancer Discov"},{"issue":"1","key":"10.1016\/j.ctrv.2024.102737_b0055","article-title":"Predicting response to immunotherapy in gastric cancer via multi-dimensional analyses of the tumour immune microenvironment","volume":"13","author":"Chen","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.ctrv.2024.102737_b0060","unstructured":"Handbook for Conducting a Literature-Based Health Assessment Using OHAT Approach for Systematic Review and Evidence Integration.; 2019."},{"issue":"11","key":"10.1016\/j.ctrv.2024.102737_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/microorganisms8111776","article-title":"Exosomes of epstein-barr virus-associated gastric carcinoma suppress dendritic cell maturation","volume":"8","author":"Hinata","year":"2020","journal-title":"Microorganisms"},{"key":"10.1016\/j.ctrv.2024.102737_b0070","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.humpath.2016.05.012","article-title":"PD-L1 expression is associated with massive lymphocyte infiltration and histology in gastric cancer","volume":"55","author":"Li","year":"2016","journal-title":"Hum Pathol"},{"issue":"1","key":"10.1016\/j.ctrv.2024.102737_b0075","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/path.2448","article-title":"Abundant expression of CXCL9 (MIG) by stromal cells that include dendritic cells and accumulation of CXCR3+ T cells in lymphocyte-rich gastric carcinoma","volume":"217","author":"Ohtani","year":"2009","journal-title":"J Pathol"},{"key":"10.1016\/j.ctrv.2024.102737_b0080","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1086\/324771","article-title":"Tumor necrosis factor-a and interleukin-10 promoter polymorphisms in epstein-barr virus-associated gastric carcinoma","volume":"185","author":"Wu","year":"2002","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.ctrv.2024.102737_b0085","doi-asserted-by":"crossref","DOI":"10.1007\/s00018-023-04702-1","article-title":"Relationships of tumor differentiation and immune infiltration in gastric cancers revealed by single-cell RNA-seq analyses","volume":"80","author":"Zhou","year":"2023","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.ctrv.2024.102737_b0090","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00428-010-0921-9","article-title":"Morphometric analysis of the balance between CXCR3+ T cells and FOXP3+ regulatory T cells in lymphocyte-rich and conventional gastric cancers","volume":"456","author":"Ohtani","year":"2010","journal-title":"Virchows Arch"},{"issue":"7","key":"10.1016\/j.ctrv.2024.102737_b0095","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19072079","article-title":"The transcriptomic landscape of gastric cancer: Insights into epstein-barr virus infected and microsatellite unstable tumors","volume":"19","author":"Gullo","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.ctrv.2024.102737_b0100","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/(SICI)1097-0215(19990820)84:4<339::AID-IJC1>3.0.CO;2-2","article-title":"Relationship between Fas-ligand expression on carcinoma cell and cytotoxic T-lymphocyte response in lymphoepithelioma-like cancer of the stomach","volume":"84","author":"Kume","year":"1999","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.ctrv.2024.102737_b0105","doi-asserted-by":"crossref","first-page":"50","DOI":"10.4110\/in.2011.11.1.50","article-title":"Expression of Epstein-Barr Virus Gene and Clonality of Infiltrated T Lymphocytes in Epstein-Barr Virus-associated Gastric Carcinoma","volume":"11","author":"Lee","year":"2011","journal-title":"Immune Netw"},{"issue":"3","key":"10.1016\/j.ctrv.2024.102737_b0110","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/jnci\/djx213","article-title":"Immune activation and benefit from avelumab in EBV-positive gastric cancer","volume":"110","author":"Panda","year":"2018","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"10.1016\/j.ctrv.2024.102737_b0115","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1356150","article-title":"Host immune response index in gastric cancer identified by comprehensive analyses of tumor immunity","volume":"6","author":"Park","year":"2017","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.ctrv.2024.102737_b0120","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1365-2559.2004.01998.x","article-title":"Gastric medullary carcinoma, a distinct entity associated with microsatellite instability-H, prominent intraepithelial lymphocytes and improved prognosis","volume":"45","author":"L\u00fc","year":"2004","journal-title":"Histopathology"},{"key":"10.1016\/j.ctrv.2024.102737_b0125","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1046\/j.1365-2559.2000.00843.x","article-title":"Epstein-Barr virus and gastric carcinoma in Western patients_comparison of pathological parameters and p53 expression in EBV-positive and negative","volume":"36","author":"Chapel","year":"2000","journal-title":"Histopathology"},{"issue":"24","key":"10.1016\/j.ctrv.2024.102737_b0130","doi-asserted-by":"crossref","first-page":"38850","DOI":"10.18632\/oncotarget.16407","article-title":"The PD-1, PD-L1 expression and CD3+ T cell infiltration in relation to outcome in advanced gastric signet-ring cell carcinoma, representing a potential biomarker for immunothera","volume":"8","author":"Jin","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.ctrv.2024.102737_b0135","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4132\/KoreanJPathol.2013.47.1.28","article-title":"Microsatellite instability status in gastric cancer; a reappraisal of its clinical significance and relationship with mucin phenotypes","volume":"47","author":"Kim","year":"2013","journal-title":"Korean J Pathol"},{"issue":"1","key":"10.1016\/j.ctrv.2024.102737_b0140","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s10120-016-0594-4","article-title":"Mismatch repair deficiency may affect clinical outcome through immune response activation in metastatic gastric cancer patients receiving first-line chemotherapy","volume":"20","author":"Giampieri","year":"2017","journal-title":"Gastric Cancer"},{"issue":"5","key":"10.1016\/j.ctrv.2024.102737_b0145","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/PAI.0000000000000761","article-title":"Expression of Indoleamine 2, 3-dioxygenase 1 (IDO1) and Tryptophanyl-tRNA Synthetase (WARS) in Gastric Cancer Molecular Subtypes","volume":"28","author":"Lu","year":"2020","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"4","key":"10.1016\/j.ctrv.2024.102737_b0150","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/PAS.0000000000001018","article-title":"Gastric Carcinomas With Lymphoid Stroma An Evaluation of the Histopathologic and Molecular Features","volume":"42","author":"Hissong","year":"2018","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.ctrv.2024.102737_b0155","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s00428-005-0066-4","article-title":"Intratumour T cells, their activation status and survival in gastric carcinomas characterised for microsatellite instability and Epstein-Barr virus infection","volume":"448","author":"Chiaravalli","year":"2006","journal-title":"Virchows Arch"},{"issue":"2","key":"10.1016\/j.ctrv.2024.102737_b0160","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1544442","article-title":"PD-L1 and immune infiltrates are differentially expressed in distinct subgroups of gastric cancer","volume":"8","author":"Angell","year":"2019","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.ctrv.2024.102737_b0165","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1007\/s10120-019-00974-4","article-title":"Differences in immune contextures among different molecular subtypes of gastric cancer and their prognostic impact","volume":"22","author":"Kim","year":"2019","journal-title":"Gastric Cancer"},{"issue":"7","key":"10.1016\/j.ctrv.2024.102737_b0170","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/01.MP.0000076980.73826.C0","article-title":"Lymphocyte-rich gastric cancer: Associations with epstein-barr virus, microsatellite instability, histology, and survival","volume":"16","author":"Grogg","year":"2003","journal-title":"Mod Pathol"},{"issue":"11","key":"10.1016\/j.ctrv.2024.102737_b0175","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1097\/PAS.0000000000000698","article-title":"Programmed Death-Ligand 1 Expression Is Common in Gastric Cancer Associated With Epstein-Barr Virus or Microsatellite Instability","volume":"40","author":"Ma","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.ctrv.2024.102737_b0180","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1356144","article-title":"Analysis of PD1, PDL1, PDL2 expression and T cells infiltration in 1014 gastric cancer patients","volume":"7","author":"Xing","year":"2018","journal-title":"Oncoimmunology"},{"issue":"1","key":"10.1016\/j.ctrv.2024.102737_b0185","doi-asserted-by":"crossref","DOI":"10.1186\/s13000-020-00979-z","article-title":"Prognostic perspectives of PD-L1 combined with tumor-infiltrating lymphocytes, Epstein-Barr virus, and microsatellite instability in gastric carcinomas","volume":"15","author":"Choi","year":"2020","journal-title":"Diagn Pathol"},{"issue":"4","key":"10.1016\/j.ctrv.2024.102737_b0190","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10040102","article-title":"EBV+ and MSI gastric cancers harbor high PD-L1\/PD-1 expression and high CD8+ intratumoral lymphocytes","volume":"10","author":"de Rosa","year":"2018","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.ctrv.2024.102737_b0195","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1002\/ijc.33322","article-title":"Immunogenic characteristics of microsatellite instability-low esophagogastric junction adenocarcinoma based on clinicopathological, molecular, immunological and survival analyses","volume":"148","author":"Imamura","year":"2021","journal-title":"Int J Cancer"},{"issue":"6","key":"10.1016\/j.ctrv.2024.102737_b0200","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/PAS.0000000000001253","article-title":"Intratumoral Immune Response to Gastric Cancer Varies by Molecular and Histologic Subtype","volume":"43","author":"Kim","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ctrv.2024.102737_b0205","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1634\/theoncologist.2018-0273","article-title":"Mismatch Repair Status of Gastric Cancer and Its Association with the Local and Systemic Immune Response","volume":"24","author":"Shin","year":"2019","journal-title":"Oncologist"},{"issue":"6","key":"10.1016\/j.ctrv.2024.102737_b0210","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.7150\/jca.40500","article-title":"Expression of PD1 PDL1 in gastric cancer at different microsatellite status and its correlation with infiltrating immune cells in the tumor microenvironment","volume":"12","author":"Wang","year":"2021","journal-title":"J Cancer"},{"key":"10.1016\/j.ctrv.2024.102737_b0215","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1007\/s00432-021-03633-3","article-title":"Apatinib combined with PD-L1 blockade synergistically enhances antitumor immune responses and promotes HEV formation in gastric cancer","volume":"147","author":"Zhang","year":"2021","journal-title":"J Cancer Res Clin Oncol"},{"issue":"3","key":"10.1016\/j.ctrv.2024.102737_b0220","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2018-000326","article-title":"Four distinct immune microenvironment subtypes in gastric adenocarcinoma with special reference to microsatellite instability","volume":"3","author":"Cho","year":"2018","journal-title":"ESMO Open"},{"issue":"7","key":"10.1016\/j.ctrv.2024.102737_b0225","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14071736","article-title":"Interspatial Distribution of Tumor and Immune Cells in Correlation with PD-L1 in Molecular Subtypes of Gastric Cancers","volume":"14","author":"Dislich","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ctrv.2024.102737_b0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2022.154124","article-title":"Solid-type poorly differentiated adenocarcinoma of the stomach: A characteristic morphology reveals a distinctive immunoregulatory tumor microenvironment","volume":"238","author":"Kawatoko","year":"2022","journal-title":"Pathol Res Pract"},{"issue":"3","key":"10.1016\/j.ctrv.2024.102737_b0235","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbaa180","article-title":"Microsatellite instability status differentially associates with intratumoral immune microenvironment in human cancers","volume":"22","author":"Zhang","year":"2021","journal-title":"Brief Bioinform"},{"issue":"1","key":"10.1016\/j.ctrv.2024.102737_b0240","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/jso.26822","article-title":"Gastric cancer with microsatellite instability displays increased thymidylate synthase expression","volume":"126","author":"Pereira","year":"2022","journal-title":"J Surg Oncol"},{"issue":"1","key":"10.1016\/j.ctrv.2024.102737_b0245","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/jnci\/djaa051","article-title":"Computational image analysis of t-cell infiltrates in resectable gastric cancer: Association with survival and molecular subtypes","volume":"113","author":"Challoner","year":"2021","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ctrv.2024.102737_b0250","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s00428-020-02932-3","article-title":"Association of tumor-infiltrating T lymphocytes with intestinal-type gastric cancer molecular subtypes and outcome","volume":"478","author":"Mansuri","year":"2021","journal-title":"Virchows Arch"},{"issue":"1","key":"10.1016\/j.ctrv.2024.102737_b0255","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/his.13504","article-title":"Expression of PD-L1, indoleamine 2,3-dioxygenase and the immune microenvironment in gastric adenocarcinoma","volume":"73","author":"Patil","year":"2018","journal-title":"Histopathology"},{"issue":"2","key":"10.1016\/j.ctrv.2024.102737_b0260","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.humpath.2013.09.004","article-title":"Prognostic implications of tumor-infiltrating FoxP3+ regulatory T cells and CD8+ cytotoxic T cells in microsatellite-unstable gastric cancers","volume":"45","author":"Kim","year":"2014","journal-title":"Hum Pathol"},{"issue":"12","key":"10.1016\/j.ctrv.2024.102737_b0265","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144192","article-title":"Prognostic implication of M2 macrophages are determined by the proportional balance of tumor associated macrophages and tumor infiltrating lymphocytes in microsatellite-unstable gastric carcinoma","volume":"10","author":"Kim","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ctrv.2024.102737_b0270","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/2684065","article-title":"Prevalence of Epstein-Barr Virus Infection and Mismatch Repair Protein Deficiency and the Correlation of Immune Markers in Tibetan Patients with Gastric Cancer","volume":"2022","author":"Shi","year":"2022","journal-title":"Biomed Res Int"},{"issue":"9","key":"10.1016\/j.ctrv.2024.102737_b0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2023.100218","article-title":"Prognostic Value of T-Cell Density in the Tumor Center and Outer Margins in Gastric Cancer","volume":"36","author":"Soeratram","year":"2023","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ctrv.2024.102737_b0280","article-title":"Intratumoral CXCR5(+)CD8(+)T associates with favorable clinical outcomes and immunogenic contexture in gastric cancer","volume":"12","author":"Wang","year":"2021","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.ctrv.2024.102737_b0285","first-page":"600","article-title":"Expression of PD-1 in Tumor Cells is Associated with Shorter Survival in Non-metastatic Intestinal-type Gastric Adenocarcinoma","volume":"21","author":"Namvar","year":"2022","journal-title":"Iran J Allergy Asthma Immunol"},{"issue":"3","key":"10.1016\/j.ctrv.2024.102737_b0290","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/ijc.33358","article-title":"Lymphocyte-activation gene 3 expression associates with poor prognosis and immunoevasive contexture in Epstein-Barr virus-positive and MLH1-defective gastric cancer patients","volume":"148","author":"Lv","year":"2021","journal-title":"Int J Cancer"},{"issue":"3","key":"10.1016\/j.ctrv.2024.102737_b0295","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s10120-023-01364-7","article-title":"Clinical relevance of PD-1 positive CD8 T-cells in gastric cancer","volume":"26","author":"Choo","year":"2023","journal-title":"Gastric Cancer"},{"issue":"9","key":"10.1016\/j.ctrv.2024.102737_b0300","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1002\/cam4.3828","article-title":"Cytolytic activity score as a biomarker for antitumor immunity and clinical outcome in patients with gastric cancer","volume":"10","author":"Hu","year":"2021","journal-title":"Cancer Med"},{"issue":"1","key":"10.1016\/j.ctrv.2024.102737_b0305","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2020.1862520","article-title":"M1-like TAMs are required for the efficacy of PD-L1\/PD-1 blockades in gastric cancer","volume":"10","author":"Zhao","year":"2021","journal-title":"Oncoimmunology"},{"issue":"2","key":"10.1016\/j.ctrv.2024.102737_b0310","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00262-020-02694-6","article-title":"Immunoscore is a strong predictor of survival in the prognosis of stage II\/III gastric cancer patients following 5-FU-based adjuvant chemotherapy","volume":"70","author":"Yun","year":"2021","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"10.1016\/j.ctrv.2024.102737_b0315","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/jmedgenet-2019-106609","article-title":"Heterogeneity of MSI-H gastric cancer identifies a subtype with worse survival","volume":"58","author":"Yang","year":"2021","journal-title":"J Med Genet"},{"issue":"2","key":"10.1016\/j.ctrv.2024.102737_b0320","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1002\/cam4.4975","article-title":"Five EMT-related genes signature predicts overall survival and immune environment in microsatellite instability-high gastric cancer","volume":"12","author":"Zhang","year":"2023","journal-title":"Cancer Med"},{"issue":"22","key":"10.1016\/j.ctrv.2024.102737_b0325","doi-asserted-by":"crossref","first-page":"32925","DOI":"10.18632\/oncotarget.9076","article-title":"Abundant PD-L1 expression in Epstein-Barr Virus-infected gastric cancers","volume":"7","author":"Derks","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ctrv.2024.102737_b0330","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/modpathol.2016.202","article-title":"Overexpression and gene amplification of PD-L1 in cancer cells and PD-L1(+) immune cells in Epstein-Barr virus-associated gastric cancer; the prognostic implications","volume":"30","author":"Saito","year":"2017","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1016\/j.ctrv.2024.102737_b0335","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1177\/10668969221080062","article-title":"Gastric Carcinoma with Lymphoid Stroma: A Combination of Mismatch Repair Deficient Medullary Type and Epstein-Barr Virus-associated Gastric Carcinomas","volume":"30","author":"Uner","year":"2022","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.ctrv.2024.102737_b0340","first-page":"1775","article-title":"Tumor microenvironment immune types in gastric cancer are associated with mismatch repair however, not HER2 status","volume":"18","author":"Valentini","year":"2019","journal-title":"Oncol Lett"},{"issue":"MAR","key":"10.1016\/j.ctrv.2024.102737_b0345","article-title":"Expression of PD-L1 and PD-1 in chemoradiotherapy-Na\u00efve esophageal and gastric adenocarcinoma: Relationship with mismatch repair status and survival","volume":"9","author":"Svensson","year":"2019","journal-title":"Front Oncol"},{"issue":"3","key":"10.1016\/j.ctrv.2024.102737_b0350","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s10120-016-0631-3","article-title":"Clinicopathological features of programmed death ligand 1 expression with tumor-infiltrating lymphocyte, mismatch repair, and Epstein-Barr virus status in a large cohort of gastric cancer patients","volume":"20","author":"Kawazoe","year":"2017","journal-title":"Gastric Cancer"},{"issue":"6","key":"10.1016\/j.ctrv.2024.102737_b0355","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.21037\/jgo-21-695","article-title":"Microsatellite instability in Chinese gastric cancer and its correlation with clinical characteristics","volume":"12","author":"Li","year":"2021","journal-title":"J Gastrointestinal Oncol"},{"key":"10.1016\/j.ctrv.2024.102737_b0360","article-title":"Human Leukocyte Antigen Class I Deficiency in Gastric Carcinoma An Adaptive Immune Evasion Strategy Most Common in Microsatellite Instable Tumors","author":"Iwasaki","year":"2021","journal-title":"Published online"},{"issue":"2","key":"10.1016\/j.ctrv.2024.102737_b0365","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/SLA.0000000000002803","article-title":"Microsatellite Instability and Programmed Cell Death-Ligand 1 Expression in Stage II\/III Gastric Cancer: Post Hoc Analysis of the CLASSIC Randomized Controlled study","volume":"270","author":"Choi","year":"2019","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.ctrv.2024.102737_b0370","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-32299-0","article-title":"Computational measurement of tumor immune microenvironment in gastric adenocarcinomas","volume":"8","author":"Chang","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.ctrv.2024.102737_b0375","article-title":"Analysis of the PD-1 Ligands Among Gastrointestinal Cancer Patients: Focus on Cancer Immunity. Front","volume":"11","author":"Dai","year":"2021","journal-title":"Oncol"},{"issue":"1","key":"10.1016\/j.ctrv.2024.102737_b0380","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-41177-2","article-title":"PD-L1 expression combined with microsatellite instability\/CD8+ tumor infiltrating lymphocytes as a useful prognostic biomarker in gastric cancer","volume":"9","author":"Morihiro","year":"2019","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.ctrv.2024.102737_b0385","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s10120-018-0836-8","article-title":"New insights into the inflamed tumor immune microenvironment of gastric cancer with lymphoid stroma: from morphology and digital analysis to gene expression","volume":"22","author":"Gullo","year":"2019","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.ctrv.2024.102737_b0390","doi-asserted-by":"crossref","unstructured":"B\u00f6ger C, Behrens HM, Mathiak M, Kr\u00fcger S, Kalthoff H, R\u00f6cken C. PD-L1 Is an Independent Prognostic Predictor in Gastric Cancer of Western Patients. Vol 7.; 2016. www.impactjournals.com\/oncotarget\/.","DOI":"10.18632\/oncotarget.8169"},{"issue":"1","key":"10.1016\/j.ctrv.2024.102737_b0395","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-81667-w","article-title":"PD-L1 overexpression in EBV-positive gastric cancer is caused by unique genomic or epigenomic mechanisms","volume":"11","author":"Nakano","year":"2021","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.ctrv.2024.102737_b0400","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-021-01080-8","article-title":"Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors in clinical trials for cancer immunotherapy","volume":"14","author":"Tang","year":"2021","journal-title":"J Hematol Oncol"},{"issue":"1","key":"10.1016\/j.ctrv.2024.102737_b0405","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2021.1954761","article-title":"Expression of the immune checkpoint receptors PD-1, LAG3, and TIM3 in the immune context of stage II and III gastric cancer by using single and chromogenic multiplex imm","volume":"10","author":"Park","year":"2021","journal-title":"Oncoimmunology"},{"issue":"7","key":"10.1016\/j.ctrv.2024.102737_b0410","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1007\/s00262-020-02806-2","article-title":"CD47 expression in gastric cancer clinical correlates and association with macrophage infiltration","volume":"70","author":"Shi","year":"2021","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.ctrv.2024.102737_b0415","article-title":"Differential Expression of the TLR4 Gene in Pan-Cancer and Its Related Mechanism. Front Cell","volume":"9","author":"Hu","year":"2021","journal-title":"Dev Biol"},{"issue":"3","key":"10.1016\/j.ctrv.2024.102737_b0420","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1080\/08923973.2018.1533968","article-title":"Identification of discrepancy between CTLA4 expression and CTLA4 activation in gastric cancer","volume":"41","author":"Xiang","year":"2019","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"10","key":"10.1016\/j.ctrv.2024.102737_b0425","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22105282","article-title":"Understanding lag-3 signaling","volume":"22","author":"Chocarro","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.ctrv.2024.102737_b0430","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1512458","article-title":"B cells in esophago-gastric adenocarcinoma are highly differentiated, organize in tertiary lymphoid structures and produce tumor-specific antibodies","volume":"8","author":"Schl\u00f6\u00dfer","year":"2019","journal-title":"Oncoimmunology"},{"issue":"9","key":"10.1016\/j.ctrv.2024.102737_b0435","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/s41416-020-0793-y","article-title":"Differential prognostic impact of CD8+ T cells based on human leucocyte antigen I and PD-L1 expression in microsatellite-unstable gastric cancer","volume":"122","author":"Kwak","year":"2020","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ctrv.2024.102737_b0440","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1007\/s00262-019-02410-z","article-title":"Clinicopathologic significance of human leukocyte antigen class I expression in patients with stage II and III gastric cancer","volume":"68","author":"Park","year":"2019","journal-title":"Cancer Immunology"},{"issue":"16","key":"10.1016\/j.ctrv.2024.102737_b0445","doi-asserted-by":"crossref","first-page":"26356","DOI":"10.18632\/oncotarget.15465","article-title":"Clinicopathologic implications of immune classification by PD-L1 expression and CD8-positive tumor-infiltrating lymphocytes in stage II and III gastric cancer patients","volume":"8","author":"Koh","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.ctrv.2024.102737_b0450","doi-asserted-by":"crossref","first-page":"84","DOI":"10.21037\/jgo-21-808","article-title":"Development and verification of a microsatellite instability-related risk signature for predicting survival and therapy effectiveness in gastric cancer","volume":"13","author":"Zhang","year":"2022","journal-title":"J Gastrointest Oncol"},{"issue":"35","key":"10.1016\/j.ctrv.2024.102737_b0455","doi-asserted-by":"crossref","first-page":"58887","DOI":"10.18632\/oncotarget.19439","article-title":"Combined prognostic effect of PD-L1 expression and immunoscore in microsatellite-unstable advanced gastric cancers","volume":"8","author":"Kim","year":"2018","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.ctrv.2024.102737_b0460","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-022-03598-y","article-title":"Association of peripheral basophils with tumor M2 macrophage infiltration and outcomes of the anti-PD-1 inhibitor plus chemotherapy combination in advanced gastric cancer","volume":"20","author":"Wu","year":"2022","journal-title":"J Transl Med"},{"key":"10.1016\/j.ctrv.2024.102737_b0465","article-title":"A Pilot Study of Baseline Spatial Genomic Heterogeneity in Primary Gastric Cancers Using Multi-Region Endoscopic Sampling. Front","volume":"10","author":"Chao","year":"2020","journal-title":"Oncol"},{"issue":"1","key":"10.1016\/j.ctrv.2024.102737_b0470","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1158\/2159-8290.CD-17-0395","article-title":"Genomic heterogeneity as a barrier to precision medicine in gastroesophageal adenocarcinoma","volume":"8","author":"Pectasides","year":"2018","journal-title":"Cancer Discov"},{"issue":"3","key":"10.1016\/j.ctrv.2024.102737_b0475","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/106689699600400304","article-title":"Epstein-Barr Virus in Gastric Carcinomas from Singapore","volume":"4","author":"Clark","year":"1997","journal-title":"Int J Surg Pathol"},{"issue":"3","key":"10.1016\/j.ctrv.2024.102737_b0480","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1053\/hupa.2001.22766","article-title":"In situ hybridization of Epstein-Barr virus in tumor cells and tumor-infiltrating lymphocytes of the gastrointestinal tract","volume":"32","author":"Cho","year":"2001","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ctrv.2024.102737_b0485","doi-asserted-by":"crossref","unstructured":"Tang F, Chen J ning, Zhang N na, et al. Expression of CCL21 by EBV-associated gastric carcinoma cells protects CD8+CCR7+ T lymphocytes from apoptosis via the mitochondria-mediated pathway. Pathology. 2018;50(6):613-621. doi:10.1016\/j.pathol.2018.05.004.","DOI":"10.1016\/j.pathol.2018.05.004"},{"issue":"1","key":"10.1016\/j.ctrv.2024.102737_b0490","doi-asserted-by":"crossref","DOI":"10.1097\/01.pas.0000176428.06629.1e","article-title":"Morphological Evidence of an Activated Cytotoxic T-Cell Infiltrate in EBV-Positive Gastric Carcinoma Preventing Lymph Node Metastases","volume":"30","author":"van Beek","year":"2006","journal-title":"J Surg Pathol"},{"issue":"23","key":"10.1016\/j.ctrv.2024.102737_b0495","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13236002","article-title":"Deep learning predicts ebv status in gastric cancer based on spatial patterns of lymphocyte infiltration","volume":"13","author":"Zhang","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.ctrv.2024.102737_b0500","doi-asserted-by":"crossref","DOI":"10.3390\/v15010176","article-title":"Tumor-Infiltrating T Cells in EBV-Associated Gastric Carcinomas Exhibit High Levels of Multiple Markers of Activation, Effector Gene Expression, and Exhaustion","volume":"15","author":"Salnikov","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.ctrv.2024.102737_b0505","first-page":"9","article-title":"Circulating Epstein-Barr virus DNA associated with hepatic impairment and its diagnostic and prognostic role in patients with gastric cancer","author":"He","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"10","key":"10.1016\/j.ctrv.2024.102737_b0510","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/j.molonc.2016.09.004","article-title":"Concordance of immune checkpoints within tumor immune contexture and their prognostic significance in gastric cancer","volume":"10","author":"Dai","year":"2016","journal-title":"Mol Oncol"},{"issue":"3","key":"10.1016\/j.ctrv.2024.102737_b0515","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1007\/s12094-021-02714-6","article-title":"Tumor immune microenvironment is influenced by frameshift mutations and tumor mutational burden in gastric cancer","volume":"24","author":"Kim","year":"2022","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.ctrv.2024.102737_b0520","doi-asserted-by":"crossref","unstructured":"Gong L ping, Chen J ning, Xiao L, et al. The implication of tumor-infiltrating lymphocytes in Epstein-Barr virus\u2013associated gastric carcinoma. Hum Pathol 2019;85:82-91. doi:10.1016\/j.humpath.2018.11.002.","DOI":"10.1016\/j.humpath.2018.11.002"},{"issue":"6","key":"10.1016\/j.ctrv.2024.102737_b0525","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1440-1827.1997.tb04509.x","article-title":"Morphological characteristics of Epstein-Barr virus-related early gastric carcinoma: A case-control study","volume":"47","author":"Arikawa","year":"1997","journal-title":"Pathol Int"},{"issue":"13","key":"10.1016\/j.ctrv.2024.102737_b0530","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1158\/1078-0432.CCR-21-0401","article-title":"A low tumor mutational burden and PTEN mutations are predictors of a negative response to PD-1 blockade in MSI-H\/dMMR gastrointestinal tumors","volume":"27","author":"Chida","year":"2021","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ctrv.2024.102737_b0535","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.humpath.2016.06.002","article-title":"Low density of CD204-positive M2-type tumor-associated macrophages in Epstein-Barr virus\u2013associated gastric cancer: a clinicopathologic study with digital image analysis","volume":"56","author":"Ichimura","year":"2016","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ctrv.2024.102737_b0540","unstructured":"Gulley ML, Pulitzer DR, Eagan PA, Schneider BG. Epstein-Barr Virus Infection Is an Early Event in Gastric Carcinogenesis and Is Independent of Bcl-2 Expression and P53 Accumulation."},{"issue":"1","key":"10.1016\/j.ctrv.2024.102737_b0545","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-021-08871-9","article-title":"The viral expression and immune status in human cancers and insights into novel biomarkers of immunotherapy","volume":"21","author":"Chen","year":"2021","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.ctrv.2024.102737_b0550","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00428-018-2332-2","article-title":"CD47 expression in Epstein-Barr virus-associated gastric carcinoma: coexistence with tumor immunity lowering the ratio of CD8+\/Foxp3+ T cells","volume":"472","author":"Abe","year":"2018","journal-title":"Virchows Arch"},{"issue":"3","key":"10.1016\/j.ctrv.2024.102737_b0555","doi-asserted-by":"crossref","first-page":"283","DOI":"10.5732\/cjc.009.10260","article-title":"Correlation of Fas\/FasL expression to cell apoptosis in Epstein-Barr virus-associated gastric carcinoma","volume":"29","author":"He","year":"2010","journal-title":"Chin J Cancer"},{"key":"10.1016\/j.ctrv.2024.102737_b0560","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1007\/s10120-018-0851-9","article-title":"Transcriptional analysis of immune genes in Epstein-Barr virus-associated gastric cancer and association with clinical outcomes","author":"Sundar","year":"2018","journal-title":"Gastric Cancer Published online"},{"issue":"5","key":"10.1016\/j.ctrv.2024.102737_b0565","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00428-016-1915-z","article-title":"In Epstein-Barr virus-associated gastric carcinoma a high density of CD66b-positive tumor-associated neutrophils is associated with intestinal-type histology and low frequency of lymph node metastasis","volume":"468","author":"Abe","year":"2016","journal-title":"Virchows Arch"},{"issue":"4","key":"10.1016\/j.ctrv.2024.102737_b0570","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00428-011-1058-1","article-title":"Inflammation in gastric adenocarcinoma of the cardia: How do EBV infection, Her2 amplification and cancer progression influence tumor-infiltrating lymphocytes?","volume":"458","author":"Haas","year":"2011","journal-title":"Virchows Arch"},{"issue":"15","key":"10.1016\/j.ctrv.2024.102737_b0575","doi-asserted-by":"crossref","first-page":"12164","DOI":"10.18632\/oncotarget.24037","article-title":"Immunoclassification characterized by CD8 and PD-L1 expression is associated with the clinical outcome of gastric cancer patients","volume":"9","author":"Wang","year":"2018","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.ctrv.2024.102737_b0580","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13373","article-title":"Identifying the key genes of Epstein-Barr virus-regulated tumour immune microenvironment of gastric carcinomas","volume":"56","author":"Zhou","year":"2023","journal-title":"Cell Prolif"},{"issue":"5","key":"10.1016\/j.ctrv.2024.102737_b0585","doi-asserted-by":"crossref","DOI":"10.1128\/mSystems.00081-18","article-title":"Epstein-Barr Virus-Positive Cancers Show Altered B-Cell Clonality","volume":"3","author":"Selitsky","year":"2018","journal-title":"mSystems"},{"issue":"5","key":"10.1016\/j.ctrv.2024.102737_b0590","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003341","article-title":"Differences in gastric carcinoma microenvironment stratify according to EBV infection intensity; implications for possible immune adjuvant therapy","volume":"9","author":"Strong","year":"2013","journal-title":"PLoS Pathog"},{"issue":"40","key":"10.1016\/j.ctrv.2024.102737_b0595","doi-asserted-by":"crossref","first-page":"67094","DOI":"10.18632\/oncotarget.17945","article-title":"Differentiated tumor immune microenvironment of Epstein-Barr virus-associated and negative gastric cancer; implication in prognosis and immunotherapy","volume":"8","author":"Ma","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ctrv.2024.102737_b0600","first-page":"5","article-title":"Accumulation Mechanisms of CD4(+)CD25(+)FOXP3(+) Regulatory T Cells in EBV-associated Gastric Carcinoma","author":"Zhang","year":"2015","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.ctrv.2024.102737_b0605","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0304-3835(03)00410-5","article-title":"The comparison of the prognosis between Epstein-Barr virus (EBV)-positive gastric carcinomas and EBV-negative ones","volume":"200","author":"Kijima","year":"2003","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ctrv.2024.102737_b0610","first-page":"10","article-title":"Clinicopathological and immunomicroenvironment characteristics of epstein-barr virus-associated gastric cancer in a chinese population","author":"Jia","year":"2021","journal-title":"Front Oncol"},{"issue":"4","key":"10.1016\/j.ctrv.2024.102737_b0615","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.ccell.2018.03.010","article-title":"Comparative molecular analysis of gastrointestinal adenocarcinomas","volume":"33","author":"Liu","year":"2018","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.ctrv.2024.102737_b0620","doi-asserted-by":"crossref","first-page":"E626","DOI":"10.1097\/SLA.0000000000004037","article-title":"Poor clinical outcomes and immunoevasive contexture in intratumoral IL-10-producing macrophages enriched gastric cancer patients","volume":"275","author":"Zhang","year":"2022","journal-title":"Ann Surg"},{"key":"10.1016\/j.ctrv.2024.102737_b0625","first-page":"247","article-title":"CD47-targeted immunotherapy unleashes antitumour immunity in Epstein-Barr virus-associated gastric cancer","author":"Duan","year":"2023","journal-title":"Clin Immunol"},{"issue":"1","key":"10.1016\/j.ctrv.2024.102737_b0630","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1053\/j.gastro.2014.09.020","article-title":"Deregulation of immune response genes in patients with epstein-barr virus-associated gastric cancer and outcomes","volume":"148","author":"Kim","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ctrv.2024.102737_b0635","first-page":"2","article-title":"12-chemokine gene signature identifies lymph node-like structures in melanoma: Potential for patient selection for immunotherapy?","author":"Messina","year":"2012","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.ctrv.2024.102737_b0640","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.annonc.2022.07.004","article-title":"Gastric cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"33","author":"Lordick","year":"2022","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.ctrv.2024.102737_b0645","doi-asserted-by":"crossref","first-page":"886","DOI":"10.4149\/neo_2022_220128N123","article-title":"The association of immune cell infiltration and prognostic value of tertiary lymphoid structures in gastric cancer","volume":"69","author":"Yu","year":"2022","journal-title":"Neoplasma"},{"key":"10.1016\/j.ctrv.2024.102737_b0650","first-page":"13","article-title":"Impact of mature tertiary lymphoid structures on prognosis and therapeutic response of Epstein-Barr virus-associated gastric cancer patients","author":"Yin","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.ctrv.2024.102737_b0655","first-page":"12","article-title":"Prognostic Value of Tumor-Infiltrating Lymphocytes and Tertiary Lymphoid Structures in Epstein-Barr Virus-Associated and -Negative Gastric Carcinoma","author":"Cheng","year":"2021","journal-title":"Front Immunol"},{"issue":"12","key":"10.1016\/j.ctrv.2024.102737_b0660","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002455","article-title":"Epstein-barr virus evades CD4 + T cell responses in lytic cycle through BZLF1-mediated downregulation of CD74 and the cooperation of vBcl-2","volume":"7","author":"Zuo","year":"2011","journal-title":"PLoS Pathog"},{"issue":"42","key":"10.1016\/j.ctrv.2024.102737_b0665","doi-asserted-by":"crossref","first-page":"E6467","DOI":"10.1073\/pnas.1605884113","article-title":"Epstein-Barr virus microRNAs reduce immune surveillance by virus-specific CD8+ T cells","volume":"113","author":"Albanese","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"10.1016\/j.ctrv.2024.102737_b0670","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.21784","article-title":"Down-regulation of locus-specific human lymphocyte antigen class I expression in Epstein-Barr virus-associated gastric cancer","volume":"106","author":"Dutta","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.ctrv.2024.102737_b0675","doi-asserted-by":"crossref","unstructured":"Koriyama C, Shinkura R, Hamasaki Y, Fujiyoshi T, Eizuru Y, Tokunaga M. Human leukocyte antigens related to epsteinbarr virus-associated gastric carcinoma in japanese patients. Vol 10.; 2001. http:\/\/journals.lww.com\/eurjcancerprev.","DOI":"10.1097\/00008469-200102000-00008"},{"issue":"1","key":"10.1016\/j.ctrv.2024.102737_b0680","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-71775-4","article-title":"High MHC-II expression in Epstein-Barr virus-associated gastric cancers suggests that tumor cells serve an important role in antigen presentation","volume":"10","author":"Ghasemi","year":"2020","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.ctrv.2024.102737_b0685","doi-asserted-by":"crossref","DOI":"10.3390\/cells9020499","article-title":"High levels of Class I major histocompatibility complex mRNA are present in epstein\u2013barr virus-associated gastric adenocarcinomas","volume":"9","author":"Ghasemi","year":"2020","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.ctrv.2024.102737_b0690","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/path.6067","article-title":"Loss of viral genome with altered immune microenvironment during tumour progression of Epstein-Barr virus-associated gastric carcinoma","volume":"260","author":"Kondo","year":"2023","journal-title":"J Pathol"},{"issue":"6","key":"10.1016\/j.ctrv.2024.102737_b0695","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers12061517","article-title":"The clinicopathological features and genetic alterations in epstein\u2013barr virus-associated gastric cancer patients after curative surgery","volume":"12","author":"Fang","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10.1016\/j.ctrv.2024.102737_b0700","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s10120-018-0820-3","article-title":"Poor prognosis in Epstein-Barr virus-negative gastric cancer with lymphoid stroma is associated with immune phenotype","volume":"21","author":"Cho","year":"2018","journal-title":"Gastric Cancer"},{"issue":"6","key":"10.1016\/j.ctrv.2024.102737_b0705","first-page":"695","article-title":"Prognostic Significance of Categorizing Gastric Carcinoma by PD-L1 Expression and Tumor Infiltrating Lymphocytes","volume":"48","author":"Noh","year":"2018","journal-title":"Ann Clin Lab Sci"},{"issue":"1","key":"10.1016\/j.ctrv.2024.102737_b0710","doi-asserted-by":"crossref","DOI":"10.1038\/s42003-019-0352-3","article-title":"Dynamic host immune response in virus-associated cancers","volume":"2","author":"Cao","year":"2019","journal-title":"Commun Biol"},{"issue":"3","key":"10.1016\/j.ctrv.2024.102737_b0715","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1093\/annonc\/mdv610","article-title":"Prognostic value of tumor-infiltrating lymphocytes in Epstein-Barr virus-associated gastric cancer","volume":"27","author":"Kang","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ctrv.2024.102737_b0720","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/gcc.22683","article-title":"Somatic mutational profiles of stage II and III gastric cancer according to tumor microenvironment immune type","volume":"58","author":"Koh","year":"2019","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.ctrv.2024.102737_b0725","doi-asserted-by":"crossref","unstructured":"Watanabe H, Enjoji M, Imai T. Gastric carcinoma with lymphoid stroma. Its morphologic characteristics and prognostic correlations. Cancer. 1976;38(1):232-243. doi:10.1002\/1097-0142(197607)38:1<232::AID-CNCR2820380135>3.0.CO;2-4.","DOI":"10.1002\/1097-0142(197607)38:1<232::AID-CNCR2820380135>3.0.CO;2-4"},{"issue":"2","key":"10.1016\/j.ctrv.2024.102737_b0730","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/his.13975","article-title":"The 2019 WHO classification of tumours of the digestive system","volume":"76","author":"Nagtegaal","year":"2020","journal-title":"Histopathology"},{"issue":"6","key":"10.1016\/j.ctrv.2024.102737_b0735","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1159\/000080473","article-title":"Relationship between Epstein-Barr virus-encoded RNA expression, apoptosis and lymphocytic infiltration in gastric carcinoma with lymphoid-rich stroma","volume":"13","author":"Cho","year":"2004","journal-title":"Med Princ Pract"},{"key":"10.1016\/j.ctrv.2024.102737_b0740","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jss.2020.12.029","article-title":"Epstein-Barr Virus Positive Gastric Cancer: A Distinct Subtype Candidate for Immunotherapy","volume":"261","author":"Pereira","year":"2021","journal-title":"J Surg Res"},{"issue":"6","key":"10.1016\/j.ctrv.2024.102737_b0745","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1093\/ajcp\/aqx096","article-title":"Categorization and comparison with solid-type colonic carcinomas","volume":"148","author":"Gonzalez","year":"2017","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"10.1016\/j.ctrv.2024.102737_b0750","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/00129039-200306000-00010","article-title":"Gastric Carcinoma With Lymphoid Stroma Incidence of EBV and Helicobacter pylori Infection","volume":"11","author":"Cho","year":"2003","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"10","key":"10.1016\/j.ctrv.2024.102737_b0755","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1016\/j.cgh.2015.04.015","article-title":"Features of Gastric Carcinoma With Lymphoid Stroma Associated With Epstein-Barr Virus","volume":"13","author":"Lim","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/j.ctrv.2024.102737_b0760","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1001\/jamaoncol.2020.3370","article-title":"Efficacy and Safety of Pembrolizumab or Pembrolizumab plus Chemotherapy vs Chemotherapy Alone for Patients with First-line, Advanced Gastric Cancer: The KEYNOTE-062 Phase 3 Randomized Clinical Trial","volume":"6","author":"Shitara","year":"2020","journal-title":"JAMA Oncol"},{"issue":"9","key":"10.1016\/j.ctrv.2024.102737_b0765","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.annonc.2021.05.803","article-title":"Molecular determinants of clinical outcomes with pembrolizumab versus paclitaxel in a randomized, open-label, phase III trial in patients with gastroesophageal adenocarcinoma","volume":"32","author":"Shitara","year":"2021","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ctrv.2024.102737_b0770","unstructured":"Sun YT, Guan WL, Zhao Q, et al. PD-1 Antibody camrelizumab for epstein-barr virus-positive metastatic gastric cancer: a single-arm, open-label, Phase 2 Trial. Vol 11.; 2021. www.ajcr.us\/."},{"issue":"1","key":"10.1016\/j.ctrv.2024.102737_b0775","doi-asserted-by":"crossref","DOI":"10.1186\/s40425-019-0514-3","article-title":"Clinicopathological and molecular features of responders to nivolumab for patients with advanced gastric cancer","volume":"7","author":"Mishima","year":"2019","journal-title":"J Immunother Cancer"},{"issue":"14","key":"10.1016\/j.ctrv.2024.102737_b0780","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1158\/1078-0432.CCR-20-0075","article-title":"The impact of molecular subtype on efficacy of chemotherapy and checkpoint inhibition in advanced gastric cancer","volume":"26","author":"Kubota","year":"2020","journal-title":"Clin Cancer Res"},{"issue":"9","key":"10.1016\/j.ctrv.2024.102737_b0785","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1038\/s41591-018-0101-z","article-title":"Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer","volume":"24","author":"Kim","year":"2018","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.ctrv.2024.102737_b0790","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2353\/jmoldx.2008.080023","article-title":"Laboratory assays for Epstein-Barr virus-related disease","volume":"10","author":"Gulley","year":"2008","journal-title":"J Mol Diagn"},{"issue":"5","key":"10.1016\/j.ctrv.2024.102737_b0795","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s10120-021-01195-4","article-title":"Optimized PD-L1 scoring of gastric cancer","volume":"24","author":"Schoemig-Markiefka","year":"2021","journal-title":"Gastric Cancer"},{"issue":"3","key":"10.1016\/j.ctrv.2024.102737_b0800","doi-asserted-by":"crossref","first-page":"661","DOI":"10.4143\/crt.2019.718","article-title":"PD-L1 testing in gastric cancer by the combined positive score of the 22C3 PharmDx and SP263 assay with clinically relevant cut-offs","volume":"52","author":"Park","year":"2020","journal-title":"Cancer Res Treat"},{"issue":"5","key":"10.1016\/j.ctrv.2024.102737_b0805","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/annonc\/mdx047","article-title":"Epstein-Barr virus-associated gastric cancer reveals intratumoral heterogeneity of PIK3CA mutations","volume":"28","author":"B\u00f6ger","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ctrv.2024.102737_b0810","first-page":"238","article-title":"Gastric cancer with Epstein-Barr virus heterogeneity: Evaluation of the frequency, clinicopathologic features, and genomic profiles","author":"Kim","year":"2022","journal-title":"Pathol Res Pract"}],"container-title":["Cancer Treatment Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737224000641?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737224000641?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T17:46:37Z","timestamp":1716399997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0305737224000641"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":162,"alternative-id":["S0305737224000641"],"URL":"https:\/\/doi.org\/10.1016\/j.ctrv.2024.102737","relation":{},"ISSN":["0305-7372"],"issn-type":[{"value":"0305-7372","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The tumor immune composition of mismatch repair deficient and Epstein-Barr virus-positive gastric cancer: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctrv.2024.102737","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102737"}}